| . | Blacks . | Whites . | Total . |
|---|---|---|---|
| Participants’ characteristics . | (N = 2856) . | (N = 8273) . | (N = 11129) . |
| Age, years, mean (SD) | 53.4 (5.8) | 54.1 (5.7) | 53.9 (5.7) |
| Gender, n (%) | |||
| Male | 1087 (38.1) | 3818 (46.2) | 4905 (44.1) |
| Female | 1769 (61.9) | 4455 (53.9) | 6224 (55.9) |
| Systolic blood pressure, mmHg, mean (SD) | |||
| Sitting | 128.6 (21.1) | 118.2 (16.8) | 120.8 (18.6) |
| Standing | 135.5 (22.5) | 121.2 (17.6) | 124.8 (20.0) |
| Supine | 134.3 (22.7) | 121.3 (17.2) | 124.7 (19.6) |
| Body mass index, kg/m2, mean (SD) | 29.3 (6.0) | 26.8 (4.7) | 27.5 (5.2) |
| Total cholesterola, mg/dl, mean (SD) | 213.7 (44.5) | 213.7 (40.2) | 213.7 (41.3) |
| High-density lipoproteina, mg/dl, mean (SD) | 55.7 (17.8) | 51.1 (16.9) | 52.2 (17.2) |
| Low-density lipoproteina, mg/dl, mean (SD) | 136.3 (42.3) | 136.5 (37.4) | 136.4 (38.7) |
| Diabetes, n (%) | 507 (17.8) | 654 (7.9) | 1161 (10.4) |
| Hypertension, n (%) | 1469 (51.4) | 1998 (24.2) | 3467 (31.2) |
| Left ventricular hypertrophy, n (%) | 150 (5.3) | 67 (0.8) | 217 (2.0) |
| Heart rate, beats/min, mean (SD) | 66.4 (10.9) | 66.0 (9.7) | 66.1 (10.0) |
| Glucoseb, mean (SD) | 117.2 (57.0) | 104.3 (29.1) | 107.6 (38.7) |
| Smoking, n (%) | |||
| Current | 850 (29.8) | 1984 (24.0) | 2834 (25.5) |
| Former | 682 (23.9) | 2859 (34.6) | 3541 (31.8) |
| Hypertension medications, n (%) | 1086 (38.0) | 1710 (20.7) | 2796 (25.1) |
| Statins, n (%) | 7 (0.3) | 45 (0.6) | 52 (0.5) |
| Family history of CHD, n (%) | 808 (35.5) | 3552 (46.8) | 4360 (44.2) |
| . | Blacks . | Whites . | Total . |
|---|---|---|---|
| Participants’ characteristics . | (N = 2856) . | (N = 8273) . | (N = 11129) . |
| Age, years, mean (SD) | 53.4 (5.8) | 54.1 (5.7) | 53.9 (5.7) |
| Gender, n (%) | |||
| Male | 1087 (38.1) | 3818 (46.2) | 4905 (44.1) |
| Female | 1769 (61.9) | 4455 (53.9) | 6224 (55.9) |
| Systolic blood pressure, mmHg, mean (SD) | |||
| Sitting | 128.6 (21.1) | 118.2 (16.8) | 120.8 (18.6) |
| Standing | 135.5 (22.5) | 121.2 (17.6) | 124.8 (20.0) |
| Supine | 134.3 (22.7) | 121.3 (17.2) | 124.7 (19.6) |
| Body mass index, kg/m2, mean (SD) | 29.3 (6.0) | 26.8 (4.7) | 27.5 (5.2) |
| Total cholesterola, mg/dl, mean (SD) | 213.7 (44.5) | 213.7 (40.2) | 213.7 (41.3) |
| High-density lipoproteina, mg/dl, mean (SD) | 55.7 (17.8) | 51.1 (16.9) | 52.2 (17.2) |
| Low-density lipoproteina, mg/dl, mean (SD) | 136.3 (42.3) | 136.5 (37.4) | 136.4 (38.7) |
| Diabetes, n (%) | 507 (17.8) | 654 (7.9) | 1161 (10.4) |
| Hypertension, n (%) | 1469 (51.4) | 1998 (24.2) | 3467 (31.2) |
| Left ventricular hypertrophy, n (%) | 150 (5.3) | 67 (0.8) | 217 (2.0) |
| Heart rate, beats/min, mean (SD) | 66.4 (10.9) | 66.0 (9.7) | 66.1 (10.0) |
| Glucoseb, mean (SD) | 117.2 (57.0) | 104.3 (29.1) | 107.6 (38.7) |
| Smoking, n (%) | |||
| Current | 850 (29.8) | 1984 (24.0) | 2834 (25.5) |
| Former | 682 (23.9) | 2859 (34.6) | 3541 (31.8) |
| Hypertension medications, n (%) | 1086 (38.0) | 1710 (20.7) | 2796 (25.1) |
| Statins, n (%) | 7 (0.3) | 45 (0.6) | 52 (0.5) |
| Family history of CHD, n (%) | 808 (35.5) | 3552 (46.8) | 4360 (44.2) |
| . | Blacks . | Whites . | Total . |
|---|---|---|---|
| Participants’ characteristics . | (N = 2856) . | (N = 8273) . | (N = 11129) . |
| Age, years, mean (SD) | 53.4 (5.8) | 54.1 (5.7) | 53.9 (5.7) |
| Gender, n (%) | |||
| Male | 1087 (38.1) | 3818 (46.2) | 4905 (44.1) |
| Female | 1769 (61.9) | 4455 (53.9) | 6224 (55.9) |
| Systolic blood pressure, mmHg, mean (SD) | |||
| Sitting | 128.6 (21.1) | 118.2 (16.8) | 120.8 (18.6) |
| Standing | 135.5 (22.5) | 121.2 (17.6) | 124.8 (20.0) |
| Supine | 134.3 (22.7) | 121.3 (17.2) | 124.7 (19.6) |
| Body mass index, kg/m2, mean (SD) | 29.3 (6.0) | 26.8 (4.7) | 27.5 (5.2) |
| Total cholesterola, mg/dl, mean (SD) | 213.7 (44.5) | 213.7 (40.2) | 213.7 (41.3) |
| High-density lipoproteina, mg/dl, mean (SD) | 55.7 (17.8) | 51.1 (16.9) | 52.2 (17.2) |
| Low-density lipoproteina, mg/dl, mean (SD) | 136.3 (42.3) | 136.5 (37.4) | 136.4 (38.7) |
| Diabetes, n (%) | 507 (17.8) | 654 (7.9) | 1161 (10.4) |
| Hypertension, n (%) | 1469 (51.4) | 1998 (24.2) | 3467 (31.2) |
| Left ventricular hypertrophy, n (%) | 150 (5.3) | 67 (0.8) | 217 (2.0) |
| Heart rate, beats/min, mean (SD) | 66.4 (10.9) | 66.0 (9.7) | 66.1 (10.0) |
| Glucoseb, mean (SD) | 117.2 (57.0) | 104.3 (29.1) | 107.6 (38.7) |
| Smoking, n (%) | |||
| Current | 850 (29.8) | 1984 (24.0) | 2834 (25.5) |
| Former | 682 (23.9) | 2859 (34.6) | 3541 (31.8) |
| Hypertension medications, n (%) | 1086 (38.0) | 1710 (20.7) | 2796 (25.1) |
| Statins, n (%) | 7 (0.3) | 45 (0.6) | 52 (0.5) |
| Family history of CHD, n (%) | 808 (35.5) | 3552 (46.8) | 4360 (44.2) |
| . | Blacks . | Whites . | Total . |
|---|---|---|---|
| Participants’ characteristics . | (N = 2856) . | (N = 8273) . | (N = 11129) . |
| Age, years, mean (SD) | 53.4 (5.8) | 54.1 (5.7) | 53.9 (5.7) |
| Gender, n (%) | |||
| Male | 1087 (38.1) | 3818 (46.2) | 4905 (44.1) |
| Female | 1769 (61.9) | 4455 (53.9) | 6224 (55.9) |
| Systolic blood pressure, mmHg, mean (SD) | |||
| Sitting | 128.6 (21.1) | 118.2 (16.8) | 120.8 (18.6) |
| Standing | 135.5 (22.5) | 121.2 (17.6) | 124.8 (20.0) |
| Supine | 134.3 (22.7) | 121.3 (17.2) | 124.7 (19.6) |
| Body mass index, kg/m2, mean (SD) | 29.3 (6.0) | 26.8 (4.7) | 27.5 (5.2) |
| Total cholesterola, mg/dl, mean (SD) | 213.7 (44.5) | 213.7 (40.2) | 213.7 (41.3) |
| High-density lipoproteina, mg/dl, mean (SD) | 55.7 (17.8) | 51.1 (16.9) | 52.2 (17.2) |
| Low-density lipoproteina, mg/dl, mean (SD) | 136.3 (42.3) | 136.5 (37.4) | 136.4 (38.7) |
| Diabetes, n (%) | 507 (17.8) | 654 (7.9) | 1161 (10.4) |
| Hypertension, n (%) | 1469 (51.4) | 1998 (24.2) | 3467 (31.2) |
| Left ventricular hypertrophy, n (%) | 150 (5.3) | 67 (0.8) | 217 (2.0) |
| Heart rate, beats/min, mean (SD) | 66.4 (10.9) | 66.0 (9.7) | 66.1 (10.0) |
| Glucoseb, mean (SD) | 117.2 (57.0) | 104.3 (29.1) | 107.6 (38.7) |
| Smoking, n (%) | |||
| Current | 850 (29.8) | 1984 (24.0) | 2834 (25.5) |
| Former | 682 (23.9) | 2859 (34.6) | 3541 (31.8) |
| Hypertension medications, n (%) | 1086 (38.0) | 1710 (20.7) | 2796 (25.1) |
| Statins, n (%) | 7 (0.3) | 45 (0.6) | 52 (0.5) |
| Family history of CHD, n (%) | 808 (35.5) | 3552 (46.8) | 4360 (44.2) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
